Tumor expression of B7-H4 predicts poor survival of patients suffering from gastric cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2010, v. 59, n. 11, p. 1707, doi. 10.1007/s00262-010-0900-7
- By:
- Publication type:
- Article
Works matching IS 03407004 AND DT 2010 AND VI 59 AND IP 11
Results: 14
1
2
Advances in cellular therapy: 5th International Symposium on the clinical use of cellular products, 19 and 20 March 2009, Nürnberg, Germany.
- Published in:
- 2010
- By:
- Publication type:
- Conference Paper/Materials
3
Aminobisphosphonate-pretreated dendritic cells trigger successful Vγ9Vδ2 T cell amplification for immunotherapy in advanced cancer patients.
- Published in:
- Cancer Immunology, Immunotherapy, 2010, v. 59, n. 11, p. 1611, doi. 10.1007/s00262-010-0887-0
- By:
- Publication type:
- Article
4
Differential gene expression in acute lymphoblastic leukemia cells surviving allogeneic transplant.
- Published in:
- Cancer Immunology, Immunotherapy, 2010, v. 59, n. 11, p. 1633, doi. 10.1007/s00262-010-0889-y
- By:
- Publication type:
- Article
5
Leukemic cell products down-regulate human dendritic cell differentiation.
- Published in:
- Cancer Immunology, Immunotherapy, 2010, v. 59, n. 11, p. 1645, doi. 10.1007/s00262-010-0890-5
- By:
- Publication type:
- Article
6
Delivery of immunostimulatory monoclonal antibodies by encapsulated hybridoma cells.
- Published in:
- Cancer Immunology, Immunotherapy, 2010, v. 59, n. 11, p. 1621, doi. 10.1007/s00262-010-0888-z
- By:
- Publication type:
- Article
7
A novel human recombinant single-chain antibody targeting CD166/ALCAM inhibits cancer cell invasion in vitro and in vivo tumour growth.
- Published in:
- Cancer Immunology, Immunotherapy, 2010, v. 59, n. 11, p. 1665, doi. 10.1007/s00262-010-0892-3
- By:
- Publication type:
- Article
8
Non-hematopoietic expression of IDO is integrally required for inflammatory tumor promotion.
- Published in:
- Cancer Immunology, Immunotherapy, 2010, v. 59, n. 11, p. 1655, doi. 10.1007/s00262-010-0891-4
- By:
- Publication type:
- Article
9
Generation of a tumor vaccine candidate based on conjugation of a MUC1 peptide to polyionic papillomavirus virus-like particles.
- Published in:
- Cancer Immunology, Immunotherapy, 2010, v. 59, n. 11, p. 1685, doi. 10.1007/s00262-010-0895-0
- By:
- Publication type:
- Article
10
Efficacy of catumaxomab in tumor spheroid killing is mediated by its trifunctional mode of action.
- Published in:
- Cancer Immunology, Immunotherapy, 2010, v. 59, n. 11, p. 1675, doi. 10.1007/s00262-010-0894-1
- By:
- Publication type:
- Article
11
Allogeneic natural killer cells for refractory lymphoma.
- Published in:
- Cancer Immunology, Immunotherapy, 2010, v. 59, n. 11, p. 1739, doi. 10.1007/s00262-010-0896-z
- By:
- Publication type:
- Article
12
Administration of embryonic stem cells generates effective antitumor immunity in mice with minor and heavy tumor load.
- Published in:
- Cancer Immunology, Immunotherapy, 2010, v. 59, n. 11, p. 1697, doi. 10.1007/s00262-010-0899-9
- By:
- Publication type:
- Article
13
Integrating individual functional moieties of CXCL10 and CXCL11 into a novel chimeric chemokine leads to synergistic antitumor effects: a strategy for chemokine-based multi-target-directed cancer therapy.
- Published in:
- Cancer Immunology, Immunotherapy, 2010, v. 59, n. 11, p. 1715, doi. 10.1007/s00262-010-0901-6
- By:
- Publication type:
- Article
14
Human papillomavirus type 16 E6-specific antitumor immunity is induced by oral administration of HPV16 E6-expressing Lactobacillus casei in C57BL/6 mice.
- Published in:
- Cancer Immunology, Immunotherapy, 2010, v. 59, n. 11, p. 1727, doi. 10.1007/s00262-010-0903-4
- By:
- Publication type:
- Article